Benzinga | Nov 8, 2021 07:31AM EST

Endo Announces Agreement With Premier To Supply VASOSTRICT Vials, Essential For COVID-19 Care

Endo International plc (NASDAQ:ENDP) today announced that its Par Sterile Products business will supply VASOSTRICT(r), vasopressin injection, USP, vial presentations to healthcare providers through Premier's Premier ProRx(r) program, helping to maintain supply continuity for a medication needed in critical care, including some of the most acute cases of COVID-19.



"We're pleased to join Premier in addressing industry drug shortages and serving as a guaranteed supplier of VASOSTRICT(r)--proudly produced in our Rochester, MI facility," said Scott Sims, Senior Vice President and General Manager, Sterile Injectables at Endo. "As a longstanding Premier partner, we welcome the opportunity to work with them via their Premier ProRx(r) program to offer VASOSTRICT(r) through their robust and highly reliable supply channel."